Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288

EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527 · cited 1×

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Sequist, L. V., Yang, J. C.-H., Yamamoto, N., O'Byrne, K., Hirsh, V., Mok, T., Geater, S. L., Orlov, S., Tsai, C.-M., Boyer, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2806 · Cited by 3,228

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Jänne, P. A., Yang, J. C.-H., Kim, D.-W., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M.-J., Kim, S.-W., Su, W.-C., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411817 · Cited by 2,116

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,507

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320

Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells

Bui, V. N. V., Daugaard, T. F., Sørensen, B. S., & Nielsen, A. L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150395 · Cited by 5

Chronic stress in cancer development and progression

Niu, X., Wu, T. H., Zeng, L., Wang, F., Lv, W., Zhang, L., & Zhou, F. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.09.034 · Cited by 7

[Role of STAT3 in Resistance of Non-small Cell Lung Cancer].

Sun, S., Jin, S., & Guo, R. (2019) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2019.07.08 · Cited by 4

Expression of ADRB2 in children with neuroblastoma and its influence on prognosis

Cao, L., Liu, Q., Ma, Y., Shao, F., Zhao, Z., Deng, X., Zhou, J., & Wang, S. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.1026156 · Cited by 3

Downregulation of GFPT2 enhances cisplatin chemotherapy sensitivity in STK11/KRAS mutant non-small cell lung cancer by regulating the hexosamine biosynthesis pathway, resisting tumor growth

Zhang, C., Yin, X., Jiang, J. H., Wang, P., & Wang, Y. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156943 · Cited by 3

Recent Computational Approaches in Understanding the Links between Molecular Stress and Cancer Metastasis

Papadaki, E., Paplomatas, P., Vlamos, P., & Vrahatis, A. G. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4030098 · Cited by 2

Neural regulation of lung cancer: from mechanisms to clinical implications

Xu, L., Sun, X., Yao, Y., & Fang, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03464-9 · Cited by 2

Cancer neuroscience: Dissecting autonomic and sensory neural regulation of tumor progression and therapeutic resistance

Sun, J., Zhang, C., Zhong, J., & Zhou, B. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218460 · Cited by 2

Molecular mechanisms and therapeutic targets in lung cancer–nerve crosstalk

Xu, Z., Huang, S., & Chu, Q. (2026) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2026.05.003 · Cited by 2

[A Review of Chronic Stress and the Initiation and Evolution of Cancer].

Liu, M., Xie, X., Li, Q., & Xu, C. S. (2021) · PubMed Central · doi:10.12182/20210160203 · Cited by 2

Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer

Schuller, H. M. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.03.04 · Cited by 2

Causal effect of beta-blockers on the risk of lung cancer: a Mendelian randomization study

Lu, Y., Luo, J., Huo, Z., Ge, F., Chen, Y., Chen, Y., Zhang, Q., Li, C., Wang, J., Gan, J., et al. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1098 · Cited by 1

Sex-specific associations between phthalate exposure and stroke risk: a cross-sectional study integrating molecular mechanisms of vascular dysfunction

Zhou, H.-Q., Cheng, K.-L., Jin, H.-J., Shen, J. Z., & Wu, D.-H. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003762 · Cited by 1

Prognostic value of emotional distress in advanced non–small cell lung cancer: a systematic review and meta-analysis

Lin, J.-J., Zhou, R., He, Z., Wang, T.-L., Zhang, Z.-X., Zhu, Y.-J., He, Y.-H., Chang, X., Chen, Y., & ZHANG, H.-B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1836242 · Cited by 1

Traditional Chinese medicine mediated tumor suppression via regulating psychological factors

Shi, Y., Gu, L., Zhang, X., & Chen, M. (2022) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2022.100162 · Cited by 1

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer

Rosell, R., Aguilar‐Hernández, A., & González‐Cao, M. (2023) · Cancers · doi:10.3390/cancers15092519 · Cited by 1

S‐ and R‐Carvedilol Prevent Benzo(a)pyrene‐Induced Lung Carcinogenesis

Shahid, A., Yeung, S., Andresen, B. T., & Huang, Y. S. (2025) · Thoracic Cancer · doi:10.1111/1759-7714.70109 · Cited by 1

Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways

Rosell, R., González‐Cao, M., Ito, M., Jordan, M. M., Gómez-Vázquez, J. L., Chen, J., Aguilar, A., & CHAIB-OUKADOUR, I. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-494

Stressing the need to overcome EGFR tyrosine kinase inhibitor resistance

Toulabi, L., & Ryan, B. M. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.03.05 · Cited by 1

Papers of note in Science Translational Medicine 9 (415)

Ferrarelli, L. K. (2017) · Science Signaling · doi:10.1126/scisignal.aar4466

Serum C-Reactive Protein Level Predicts Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations

Koyama, N., Aoshiba, K., & Nakamura, H. (2020) · Cancer Investigation · doi:10.1080/07357907.2020.1721522

Tumor immune microenvironment in non-small cell lung cancer with EGFR mutation before and after EGFR-TKIs treatmentPreprint

wang, C., liu, L., li, S., Bai, H., & Wang, J. (2021) · doi:10.22541/au.161393354.40757172/v1

Stressors: Psychological and neurobiological processes

Anisman, H., & Kusnecov, A. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91904-3.00005-7

Research Progress of Anxiety and Depression in Patients after Radical Gastrectomy for Gastric Cancer

Zhang, H., & Zhang, J. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1281041

Mechanism of chronic stress to promote tumor development and the intervention.

Liu, Y., Zeng, Y., Li, Y., Ke, J., Pan, Y., Liu, X., Peng, Y., & Wu, F. (2022) · PubMed Central · doi:10.11817/j.issn.1672-7347.2022.210589

Systemic Interactions Between Cancer and the Nervous System

Wu, Y., & Borniger, J. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-32429-1_10 · Cited by 2

Blocking β-adrenergic receptor signaling enhances the sensitivity of AML to MCL-1 inhibitor S63845

Kuang, W., Zeng, C., Xie, Q., Zhou, M., Li, X., Wu, B., Lan, Y., Liu, W., Zhou, G., & Cao, S. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123894

Fucoidan for Lung Cancer Therapy: A Review of Classification, Mechanisms, and Preclinical Studies

Uyen, N. T. T., Yang, A. W. H., Nguyen, Q.-A. N., Hung, A., Ngo, S. T., & Lenon, G. B. (2025) · ACS Omega · doi:10.1021/acsomega.5c08144 · Cited by 1

Additional file 8 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134559

Additional file 6 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134547

Additional file 2 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134514

Additional file 10 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134502

Additional file 5 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, 任正刚, & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134541

Additional file 1 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, 任正刚, & Chen, R. (2020) · Figshare · doi:10.6084/m9.figshare.12134508

Additional file 3 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134523

Additional file 9 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134562

Additional file 4 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R. (2020) · Figshare · doi:10.6084/m9.figshare.12134529

Additional file 7 of Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop

Lin, X.-H., Liu, H.-H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D.-M., 崔杰峰, Ren, Z.-G., & Chen, R.-X. (2020) · Figshare · doi:10.6084/m9.figshare.12134553

EGFR and IRE1α pathways are associated with distinct immunomodulatory gene expression profiles in NSCLC cells with acquired resistance to EGFR TKIs

Wang, Y.-S., Chou, H., Liao, E., Chen, H.-Y., Lin, M.-W., Wei, Y.-S., Lin, L., Chang, Y., Meng, H., Wen, Y., et al. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110762

Tumor Microenvironment–Induced IFITM3 Activates MET–AKT Signaling to Drive Osimertinib Resistance in EGFR-Mutant NSCLC

Petrovic, M., & Jovanovic, A. (2023) · Archive of International Journal of Cancer and Allied Science · doi:10.51847/8a8ywycgnk

Effets du cisplatine sur la sensibilité des cancers bronchiques non à petites cellules EGFR sauvage aux inhibiteurs de tyrosine kinase anti EGFR

Raimbourg, J. (2018) · theses.fr (ABES) · doi:10.70675/5416605az66abz4feeza159z5f8b539e3da8

Contribution de la polarité cholinergique du système nerveux autonome à la pathogenèse de l’hépatocarcinome : implications en pharmacologie

Hernandez, C. A. (2024) · theses.fr (ABES) · doi:10.70675/3e1a7f7azeed3z47b4z9afdz7e2883de7a37

Neural state as a determinant of tumor immunity in lung cancer

Yu, J., Qi, J., Que, Z., Kong, X., & Feng, Y. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108261

Metabolic Crosstalk Between Host and Tumor as a Circuit of Resilience in Cancer Therapy

Wang, J., Wu, H., Wang, T., & Nie, M. (2026) · Cells · doi:10.3390/cells15111008

Macrophage Membrane-Engineered Nanovesicles Co-Delivering Ruxolitinib and Carvedilol for Synergistic Therapy of Cisplatin-Resistant Lung Cancer

Gao, C., Yun, Z., Bai, X., Wang, P. H., Ji, W., Zhu, Y., Song, X., He, Y. Q., Yong, X., Zhang, L., et al. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c01382

Stress Biology in Cancer: Neuroendocrine–Immune Mechanisms Linking Tumor Progression to Translational Interventions

Ma, C., Ma, C., Xing, X., Sun, C., Guan, L., Schiöth, H. B., & Liu, W. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0053

Abstract 4662: Beta blockers abrogate EGFR TKI resistance induced by adrenergic receptor-mediated upregulation of IL-6 and modulation of the LKB1/AMPK/mTOR axis

Nilsson, M. B., Sun, H., Diao, L., Tong, P., Fan, Y.-H., Tran, H. T., Liu, D., Armaiz-Peña, G. N., Wang, J., Rowe, P. J., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-4662

Chronic Stress Hormones May Promote Resistance to EGFR Inhibitors

(2017) · Oncology Times · doi:10.1097/01.cot.0000527904.90180.2e

The impact of ß-blockers in non–small cell lung cancer patients treated with Epidermal Growth Factor Receptor Kinase Inhibitors, Taiwan NHIRD database study.

Fan, G. W., & Lin, C. (2018) · Lung Cancer · doi:10.1183/13993003.congress-2018.pa2855

Blocking beta adrenergic signaling may be a target for overcoming EGFR TKI resistance.

Heo, E. Y., Lee, M., Lee, J., Kim, D. K., & Chung, H. S. (2018) · Lung Cancer · doi:10.1183/13993003.congress-2018.pa2854

2060eP Prognostic impact of concomitant beta-blocker use on survival in EGFR-mutant metastatic non-small cell lung cancer patients treated with erlotinib

Yıldız, O., Aykut, T., Kaya, B. E., Genç, Ö., Gürbüz, A. F., Eryılmaz, M. K., Araz, M., & Artaç, M. (2025) · Annals of Oncology · doi:10.1016/j.annonc.2025.08.2681